AML is 11 diseases – study

Acute myeloid leukaemia is at least 11 different diseases, British researchers announced last night.

The conclusions come from a genetic analysis of patients with the disease.

Researchers said they found different "constellations" of genetic changes and distinctive clinical features in at least 11 groups of patients.

Most patients also had a unique, personal combination of genetic changes.

The research led by the Wellcome Trust Sanger Institute, Cambridge, was published in the New England Journal of Medicine.

The researchers say the findings explain why patient response to treatment varies so much.

The findings come from a study of some 1,540 patients and the analysis of some 100 genes linked to the disease. It also involved Ulm University and the Memorial Sloan Kettering Cancer Center, New York.

Researcher Dr Peter Campbell said: This is our first detailed look at how the genetic complexity of a cancer impacts on its clinical outcomes. Two people may have what looks like the same leukaemia down the microscope, but we find extensive differences between those leukaemias at the genetic level.

"These genetic differences can explain so much of why one of those patients will be cured, while the other will not, despite receiving the exact same treatment.

“We have shown that acute myeloid leukaemia is an umbrella term for a group of at least 11 different types of leukaemia. We can now start to decode these genetics to shape clinical trials and develop diagnostics.”

Professor Hartmut Döhner, of Ulm University, said: “This landmark study has showcased the importance of international collaboration between academic institutions and clinical trials and the large scale of the study.

"These results represent a major step forward in translating the exciting findings from molecular genetics into better disease classification, diagnosis, and improved care of our patients with acute myeloid leukaemia.”

E. Papaemmanuil and M. Gerstung et al. Genomic classification and prognosis in acute myeloid leukemia. New England Journal of Medicine 8 June 2016

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index